Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
64
ONTTF Quote, Financials, Valuation and Earnings
Last price:
$1.78
Seasonality move
:
-13.09%
Day range:
$1.67 - $1.94
52-week range:
$1.07 - $3.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.36x
P/B ratio:
3.81x
Volume:
10.7K
Avg. volume:
36.6K
1-year change:
6.93%
Market cap:
$1.7B
Revenue:
$234.1M
EPS (TTM):
-$0.19
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ONTTF
Oxford Nanopore Technologies Plc
|
-- | -- | -- | -- | -- |
|
APM
Aptorum Group Ltd.
|
-- | -- | -- | -- | -- |
|
AUTL
Autolus Therapeutics Plc
|
$21.3M | -$0.23 | 84624.25% | -288.08% | $9.52 |
|
BDRX
Biodexa Pharmaceuticals Plc
|
-- | -- | -- | -- | $17.94 |
|
NCNA
NuCana Plc
|
-- | -$0.01 | -- | -99.69% | $104.00 |
|
TLSA
Tiziana Life Sciences Ltd.
|
-- | -- | -- | -- | $7.99 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ONTTF
Oxford Nanopore Technologies Plc
|
$1.78 | -- | $1.7B | -- | $0.00 | 0% | 6.36x |
|
APM
Aptorum Group Ltd.
|
$1.19 | -- | $8.5M | 8.94x | $0.00 | 0% | 6.32x |
|
AUTL
Autolus Therapeutics Plc
|
$1.68 | $9.52 | $447.1M | -- | $0.00 | 0% | 8.72x |
|
BDRX
Biodexa Pharmaceuticals Plc
|
$2.87 | $17.94 | $2.4M | -- | $0.00 | 0% | 0.73x |
|
NCNA
NuCana Plc
|
$3.34 | $104.00 | $13.9M | -- | $0.00 | 0% | -- |
|
TLSA
Tiziana Life Sciences Ltd.
|
$1.53 | $7.99 | $181.8M | -- | $0.00 | 0% | 2,803.69x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ONTTF
Oxford Nanopore Technologies Plc
|
-- | 1.579 | -- | 3.66x |
|
APM
Aptorum Group Ltd.
|
-- | -9.132 | -- | -- |
|
AUTL
Autolus Therapeutics Plc
|
55.06% | 3.892 | 74.96% | 4.83x |
|
BDRX
Biodexa Pharmaceuticals Plc
|
-- | 3.246 | -- | 1.20x |
|
NCNA
NuCana Plc
|
0.52% | -0.585 | 0.95% | 4.03x |
|
TLSA
Tiziana Life Sciences Ltd.
|
-- | 0.602 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ONTTF
Oxford Nanopore Technologies Plc
|
-- | -- | -24.36% | -24.36% | -- | -- |
|
APM
Aptorum Group Ltd.
|
-- | -- | -- | -- | -- | -- |
|
AUTL
Autolus Therapeutics Plc
|
-$10.8M | -$71.2M | -32.68% | -59.51% | -337.93% | -$79.9M |
|
BDRX
Biodexa Pharmaceuticals Plc
|
-- | -- | -160.77% | -160.77% | -- | -- |
|
NCNA
NuCana Plc
|
-$93K | -$4.8M | -281.73% | -286.82% | -- | $1.5M |
|
TLSA
Tiziana Life Sciences Ltd.
|
-- | -- | -- | -- | -- | -- |
Oxford Nanopore Technologies Plc vs. Competitors
-
Which has Higher Returns ONTTF or APM?
Aptorum Group Ltd. has a net margin of -- compared to Oxford Nanopore Technologies Plc's net margin of --. Oxford Nanopore Technologies Plc's return on equity of -24.36% beat Aptorum Group Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ONTTFOxford Nanopore Technologies Plc-- -- $735.7M APMAptorum Group Ltd.-- -- -- -
What do Analysts Say About ONTTF or APM?
Oxford Nanopore Technologies Plc has a consensus price target of --, signalling downside risk potential of --. On the other hand Aptorum Group Ltd. has an analysts' consensus of -- which suggests that it could grow by 13292.86%. Given that Aptorum Group Ltd. has higher upside potential than Oxford Nanopore Technologies Plc, analysts believe Aptorum Group Ltd. is more attractive than Oxford Nanopore Technologies Plc.
Company Buy Ratings Hold Ratings Sell Ratings ONTTFOxford Nanopore Technologies Plc0 0 0 APMAptorum Group Ltd.0 0 0 -
Is ONTTF or APM More Risky?
Oxford Nanopore Technologies Plc has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Aptorum Group Ltd. has a beta of -0.206, suggesting its less volatile than the S&P 500 by 120.612%.
-
Which is a Better Dividend Stock ONTTF or APM?
Oxford Nanopore Technologies Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aptorum Group Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oxford Nanopore Technologies Plc pays -- of its earnings as a dividend. Aptorum Group Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ONTTF or APM?
Oxford Nanopore Technologies Plc quarterly revenues are --, which are smaller than Aptorum Group Ltd. quarterly revenues of --. Oxford Nanopore Technologies Plc's net income of -- is lower than Aptorum Group Ltd.'s net income of --. Notably, Oxford Nanopore Technologies Plc's price-to-earnings ratio is -- while Aptorum Group Ltd.'s PE ratio is 8.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oxford Nanopore Technologies Plc is 6.36x versus 6.32x for Aptorum Group Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ONTTFOxford Nanopore Technologies Plc6.36x -- -- -- APMAptorum Group Ltd.6.32x 8.94x -- --
-
Which has Higher Returns ONTTF or AUTL?
Autolus Therapeutics Plc has a net margin of -- compared to Oxford Nanopore Technologies Plc's net margin of -373.3%. Oxford Nanopore Technologies Plc's return on equity of -24.36% beat Autolus Therapeutics Plc's return on equity of -59.51%.
Company Gross Margin Earnings Per Share Invested Capital ONTTFOxford Nanopore Technologies Plc-- -- $735.7M AUTLAutolus Therapeutics Plc-51.21% -$0.30 $590.6M -
What do Analysts Say About ONTTF or AUTL?
Oxford Nanopore Technologies Plc has a consensus price target of --, signalling downside risk potential of --. On the other hand Autolus Therapeutics Plc has an analysts' consensus of $9.52 which suggests that it could grow by 480.62%. Given that Autolus Therapeutics Plc has higher upside potential than Oxford Nanopore Technologies Plc, analysts believe Autolus Therapeutics Plc is more attractive than Oxford Nanopore Technologies Plc.
Company Buy Ratings Hold Ratings Sell Ratings ONTTFOxford Nanopore Technologies Plc0 0 0 AUTLAutolus Therapeutics Plc9 0 0 -
Is ONTTF or AUTL More Risky?
Oxford Nanopore Technologies Plc has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Autolus Therapeutics Plc has a beta of 2.013, suggesting its more volatile than the S&P 500 by 101.348%.
-
Which is a Better Dividend Stock ONTTF or AUTL?
Oxford Nanopore Technologies Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Autolus Therapeutics Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oxford Nanopore Technologies Plc pays -- of its earnings as a dividend. Autolus Therapeutics Plc pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ONTTF or AUTL?
Oxford Nanopore Technologies Plc quarterly revenues are --, which are smaller than Autolus Therapeutics Plc quarterly revenues of $21.1M. Oxford Nanopore Technologies Plc's net income of -- is lower than Autolus Therapeutics Plc's net income of -$78.6M. Notably, Oxford Nanopore Technologies Plc's price-to-earnings ratio is -- while Autolus Therapeutics Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oxford Nanopore Technologies Plc is 6.36x versus 8.72x for Autolus Therapeutics Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ONTTFOxford Nanopore Technologies Plc6.36x -- -- -- AUTLAutolus Therapeutics Plc8.72x -- $21.1M -$78.6M
-
Which has Higher Returns ONTTF or BDRX?
Biodexa Pharmaceuticals Plc has a net margin of -- compared to Oxford Nanopore Technologies Plc's net margin of --. Oxford Nanopore Technologies Plc's return on equity of -24.36% beat Biodexa Pharmaceuticals Plc's return on equity of -160.77%.
Company Gross Margin Earnings Per Share Invested Capital ONTTFOxford Nanopore Technologies Plc-- -- $735.7M BDRXBiodexa Pharmaceuticals Plc-- -- $6M -
What do Analysts Say About ONTTF or BDRX?
Oxford Nanopore Technologies Plc has a consensus price target of --, signalling downside risk potential of --. On the other hand Biodexa Pharmaceuticals Plc has an analysts' consensus of $17.94 which suggests that it could grow by 5406.23%. Given that Biodexa Pharmaceuticals Plc has higher upside potential than Oxford Nanopore Technologies Plc, analysts believe Biodexa Pharmaceuticals Plc is more attractive than Oxford Nanopore Technologies Plc.
Company Buy Ratings Hold Ratings Sell Ratings ONTTFOxford Nanopore Technologies Plc0 0 0 BDRXBiodexa Pharmaceuticals Plc1 0 0 -
Is ONTTF or BDRX More Risky?
Oxford Nanopore Technologies Plc has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Biodexa Pharmaceuticals Plc has a beta of 0.955, suggesting its less volatile than the S&P 500 by 4.507%.
-
Which is a Better Dividend Stock ONTTF or BDRX?
Oxford Nanopore Technologies Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biodexa Pharmaceuticals Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oxford Nanopore Technologies Plc pays -- of its earnings as a dividend. Biodexa Pharmaceuticals Plc pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ONTTF or BDRX?
Oxford Nanopore Technologies Plc quarterly revenues are --, which are smaller than Biodexa Pharmaceuticals Plc quarterly revenues of --. Oxford Nanopore Technologies Plc's net income of -- is lower than Biodexa Pharmaceuticals Plc's net income of --. Notably, Oxford Nanopore Technologies Plc's price-to-earnings ratio is -- while Biodexa Pharmaceuticals Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oxford Nanopore Technologies Plc is 6.36x versus 0.73x for Biodexa Pharmaceuticals Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ONTTFOxford Nanopore Technologies Plc6.36x -- -- -- BDRXBiodexa Pharmaceuticals Plc0.73x -- -- --
-
Which has Higher Returns ONTTF or NCNA?
NuCana Plc has a net margin of -- compared to Oxford Nanopore Technologies Plc's net margin of --. Oxford Nanopore Technologies Plc's return on equity of -24.36% beat NuCana Plc's return on equity of -286.82%.
Company Gross Margin Earnings Per Share Invested Capital ONTTFOxford Nanopore Technologies Plc-- -- $735.7M NCNANuCana Plc-- -$0.13 $35.1M -
What do Analysts Say About ONTTF or NCNA?
Oxford Nanopore Technologies Plc has a consensus price target of --, signalling downside risk potential of --. On the other hand NuCana Plc has an analysts' consensus of $104.00 which suggests that it could grow by 622654.49%. Given that NuCana Plc has higher upside potential than Oxford Nanopore Technologies Plc, analysts believe NuCana Plc is more attractive than Oxford Nanopore Technologies Plc.
Company Buy Ratings Hold Ratings Sell Ratings ONTTFOxford Nanopore Technologies Plc0 0 0 NCNANuCana Plc0 1 0 -
Is ONTTF or NCNA More Risky?
Oxford Nanopore Technologies Plc has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NuCana Plc has a beta of 1.595, suggesting its more volatile than the S&P 500 by 59.472%.
-
Which is a Better Dividend Stock ONTTF or NCNA?
Oxford Nanopore Technologies Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NuCana Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oxford Nanopore Technologies Plc pays -- of its earnings as a dividend. NuCana Plc pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ONTTF or NCNA?
Oxford Nanopore Technologies Plc quarterly revenues are --, which are smaller than NuCana Plc quarterly revenues of --. Oxford Nanopore Technologies Plc's net income of -- is lower than NuCana Plc's net income of -$378.9K. Notably, Oxford Nanopore Technologies Plc's price-to-earnings ratio is -- while NuCana Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oxford Nanopore Technologies Plc is 6.36x versus -- for NuCana Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ONTTFOxford Nanopore Technologies Plc6.36x -- -- -- NCNANuCana Plc-- -- -- -$378.9K
-
Which has Higher Returns ONTTF or TLSA?
Tiziana Life Sciences Ltd. has a net margin of -- compared to Oxford Nanopore Technologies Plc's net margin of --. Oxford Nanopore Technologies Plc's return on equity of -24.36% beat Tiziana Life Sciences Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ONTTFOxford Nanopore Technologies Plc-- -- $735.7M TLSATiziana Life Sciences Ltd.-- -- -- -
What do Analysts Say About ONTTF or TLSA?
Oxford Nanopore Technologies Plc has a consensus price target of --, signalling downside risk potential of --. On the other hand Tiziana Life Sciences Ltd. has an analysts' consensus of $7.99 which suggests that it could grow by 422.11%. Given that Tiziana Life Sciences Ltd. has higher upside potential than Oxford Nanopore Technologies Plc, analysts believe Tiziana Life Sciences Ltd. is more attractive than Oxford Nanopore Technologies Plc.
Company Buy Ratings Hold Ratings Sell Ratings ONTTFOxford Nanopore Technologies Plc0 0 0 TLSATiziana Life Sciences Ltd.1 0 0 -
Is ONTTF or TLSA More Risky?
Oxford Nanopore Technologies Plc has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tiziana Life Sciences Ltd. has a beta of -0.047, suggesting its less volatile than the S&P 500 by 104.653%.
-
Which is a Better Dividend Stock ONTTF or TLSA?
Oxford Nanopore Technologies Plc has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tiziana Life Sciences Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oxford Nanopore Technologies Plc pays -- of its earnings as a dividend. Tiziana Life Sciences Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ONTTF or TLSA?
Oxford Nanopore Technologies Plc quarterly revenues are --, which are smaller than Tiziana Life Sciences Ltd. quarterly revenues of --. Oxford Nanopore Technologies Plc's net income of -- is lower than Tiziana Life Sciences Ltd.'s net income of --. Notably, Oxford Nanopore Technologies Plc's price-to-earnings ratio is -- while Tiziana Life Sciences Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oxford Nanopore Technologies Plc is 6.36x versus 2,803.69x for Tiziana Life Sciences Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ONTTFOxford Nanopore Technologies Plc6.36x -- -- -- TLSATiziana Life Sciences Ltd.2,803.69x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
